Osaic Holdings’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Osaic Holdings’s Portfolio BIB Stock Details BIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-300	Closed	-$19.1K	–	7420
2024 Q3	$19.1K	Hold	300	–	–	﹤0.01%	5416
2024 Q2	$17.8K	Buy	+300	New	+$16.6K	﹤0.01%	5422
2022 Q2	–	Sell	-200	Closed	-$12K	–	7335
2022 Q1	$12K	Hold	200	–	–	﹤0.01%	6013
2021 Q4	$16K	Sell	200 -65	-25%	-$5.57K	﹤0.01%	5941
2021 Q3	$25K	Buy	265 +65	+33%	+$6.57K	﹤0.01%	5610
2021 Q2	$20K	Hold	200	–	–	﹤0.01%	5650
2021 Q1	$17K	Hold	200	–	–	﹤0.01%	5581
2020 Q4	$17K	Hold	200	–	–	﹤0.01%	5239
2020 Q3	$14K	Hold	200	–	–	﹤0.01%	5098
2020 Q2	$15K	Sell	200 -100	-33%	-$6.39K	﹤0.01%	4951
2020 Q1	$14K	Buy	+300	New	+$16.7K	﹤0.01%	4821

Other funds holding BIB

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

CIC

Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

WWM

Westwood Wealth Management Los Angeles, California $255M AUM 54.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

CCWM

Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

PWM

Palumbo Wealth Management Great Neck, New York $410M AUM 32.56% 1-Year Est. Return

CWM

Crowley Wealth Management Wilmington, Delaware $126M AUM 23.04% 1-Year Est. Return

Osaic Holdings's BIB Position: Q4 2024 in Review

Osaic Holdings sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q4 2024, closing a stake of 300 shares — an estimated $19.1K sold.

Osaic Holdings first reported a position in BIB in Q1 2020 and held it in 11 quarters. The position peaked at $25K in Q3 2021. 24 funds tracked by Wall St. Rank hold BIB as of Q4 2024.

Osaic Holdings reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q4 2024 after selling out during the quarter.
Osaic Holdings sold 300 ProShares Ultra NASDAQ Biotechnology shares in Q4 2024, an estimated $19.1K.
Osaic Holdings first reported a position in ProShares Ultra NASDAQ Biotechnology in Q1 2020 and held it in 11 quarters.
Osaic Holdings's ProShares Ultra NASDAQ Biotechnology position peaked at $25K in Q3 2021.
24 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q4 2024.

Based on Osaic Holdings's 13F filing for Q4 2024, filed 7 Feb 2025.